Tj Biopharma Co., Ltd.
Clinical trials sponsored by Tj Biopharma Co., Ltd., explained in plain language.
-
New triple therapy aims to shrink lung tumors better than current standard
Disease control OngoingThis study tests whether adding the experimental drug uliledlimab to a standard immunotherapy (sintilimab) and chemotherapy can help people with advanced non-small cell lung cancer live longer without their cancer growing. About 150 adults who have not had prior treatment for the…
Phase: PHASE2 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New drug cocktail aims to shrink tough lung cancers
Disease control OngoingThis study tests whether adding a new drug (uliledlimab) to an immunotherapy (toripalimab) works better than either toripalimab or pembrolizumab alone for people with advanced non-small cell lung cancer that has certain markers (PD-L1 and CD73). About 450 adults who have not had …
Phase: PHASE2, PHASE3 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:37 UTC